Physicians pioneer the use of stereotactic body radiation for deadly kidney cancer complication
Investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer. The stereotactic ablative radiation therapy (SABR) was used to treat inferior vena cava tumor thrombus (IVC-TT) that reached the heart, a complication of kidney cancer in which the tumor extends into the venous system ? the system of veins that return blood to the heart. An estimated 4 to 36 percent of kidney tumors are associated with IVC-TT. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 7, 2015 Category: Science Source Type: news

Physicians pioneer the use of stereotactic body radiation for deadly kidney cancer complication
(UT Southwestern Medical Center) UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 7, 2015 Category: Global & Universal Source Type: news

Erythropoietin combined with radiation therapy does not improve local-regional control in anemic patients with head and neck cancer
Long-term analysis of Radiation Therapy Oncology Group 9903 demonstrates that the addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma who receive radiation therapy or chemoradiation, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 6, 2015 Category: Science Source Type: news

Erythropoietin combined with radiation therapy does not improve local-regional control in anemic patients with head and neck cancer
(American Society for Radiation Oncology) Long-term analysis of Radiation Therapy Oncology Group 9903 demonstrates that the addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma who receive radiation therapy or chemoradiation, according to a study published in the April 1, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2015 Category: Cancer & Oncology Source Type: news

Does Radiation Right After Prostatectomy Save Lives?Does Radiation Right After Prostatectomy Save Lives?
Dr Gerald Chodak reviews the evidence on adjuvant vs salvage radiation therapy in high-risk men who have undergone radical prostatectomy for prostate cancer. Medscape Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - April 3, 2015 Category: Urology & Nephrology Tags: Urology Commentary Source Type: news

Radiation After Prostatectomy: Debate Over TimingRadiation After Prostatectomy: Debate Over Timing
Two longitudinal studies provide additional fuel to the debate over adjuvant or salvage radiation therapy in appropriate patients with prostate cancer. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Edith Mitchell
Clinical Professor of Medicine and Medical OncologyEdith Peterson Mitchell, MD, is Clinical Professor of Medicine and Medical Oncology and Program Leader in Gastrointestinal Oncology at Thomas Jefferson University. In addition, she holds the positions of Associate Director of Diversity Programs for the Kimmel Cancer Center at Jefferson and Director of the Kimmel Cancer Center to Eliminate Cancer Disparities. Dr. Mitchell received a B.S. in biochemistry "with distinction" from Tennessee State University and her medical degree from the Medical College of Virginia in Richmond. In 1973, while attending medical school...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news

Edith Mitchell, M.D.
Clinical Professor of Medicine and Medical OncologyEdith Peterson Mitchell, MD, is Clinical Professor of Medicine and Medical Oncology and Program Leader in Gastrointestinal Oncology at Thomas Jefferson University. In addition, she holds the positions of Associate Director of Diversity Programs for the Kimmel Cancer Center at Jefferson and Director of the Kimmel Cancer Center to Eliminate Cancer Disparities. Dr. Mitchell received a B.S. in biochemistry "with distinction" from Tennessee State University and her medical degree from the Medical College of Virginia in Richmond. In 1973, while attending medical school...
Source: PHRMA - March 30, 2015 Category: Pharmaceuticals Authors: Ali Source Type: news

Varian launches business unit in Algeria
Radiation therapy vendor Varian Medical Systems has formed Varian Medical Systems (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 17, 2015 Category: Radiology Source Type: news

ViewRay sets $52m IPO terms
ViewRay sets the price range for its pending initial public offering, which would fetch $52 million at the midpoint. ViewRay today set the terms for its pending initial public offering, saying it plans to float 4 million shares at $12 to $14 apiece. At the midpoint of the range, the MRI-guided radiation therapy maker's IPO would fetch $52 million. ViewRay Inc.News Well, Initial Public Offering (IPO), Radiosurgeryread more (Source: Mass Device)
Source: Mass Device - March 13, 2015 Category: Medical Equipment Authors: Brad Perriello Source Type: news

Concurrent chemoradiation treatment at high-volume facilities improves survival for NSCLC
Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 11, 2015 Category: Science Source Type: news

New ILROG Guidelines for Pediatric Hodgkin's LymphomaNew ILROG Guidelines for Pediatric Hodgkin's Lymphoma
The International Lymphoma Radiation Oncology Group (ILROG) has issued new guidelines for the treatment of pediatric Hodgkin's lymphoma with radiation therapy. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 11, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Concurrent chemoradiation treatment at high-volume facilities improves survival for NSCLC
(International Association for the Study of Lung Cancer) Patients treated with definitive concurrent chemotherapy and radiation therapy for stage III non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, whether or not they are academic or community cancer centers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2015 Category: Cancer & Oncology Source Type: news

Molecules in prostate tumors might predict whether RT can help prevent recurrence
(Ohio State University Wexner Medical Center) A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels indicate their cancer has recurred after surgical removal of the prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2015 Category: Cancer & Oncology Source Type: news

Radiation, immunotherapy form best team against melanoma
The combination of radiation therapy and two immunotherapies may be optimal (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 10, 2015 Category: Radiology Source Type: news

Varian plans new hub in eastern U.S.
Radiation therapy vendor Varian Medical Systems said it will expand its operations (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 10, 2015 Category: Radiology Source Type: news

Clinical trial suggests combination therapy is best for low-grade brain tumors
(Ohio State University Wexner Medical Center) New clinical-trial findings provide further evidence that combining chemotherapy with radiation therapy is the best treatment for people with a low-grade form of brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 10, 2015 Category: Cancer & Oncology Source Type: news

Radiation plus immunotherapy combo revs up immune system to better attack melanoma, Penn study suggests
(University of Pennsylvania School of Medicine) Treating metastatic melanoma with a triple threat --including radiation therapy and two immunotherapies that target the CTLA4 and PD-1 pathways -- could elicit an optimal response in more patients, one that will boost the immune system's attack on the disease, suggests a new study from a multidisciplinary team of researchers from Penn's Abramson Cancer Center published today in Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 9, 2015 Category: Cancer & Oncology Source Type: news

First-of-its kind reference on pelvic malignancies
(Loyola University Health System) Loyola University Medical Center radiation oncologist William Small, Jr., MD is co-editor of Pelvic Malignancy and its Consequences, the first-of-its kind stand-alone reference on the subject. The book provides a state-of-the-art review of the role of radiation therapy in various pelvic malignancies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2015 Category: Cancer & Oncology Source Type: news

ILROG issues treatment guidelines for pediatric Hodgkin lymphoma
(American Society for Radiation Oncology) The International Lymphoma Radiation Oncology Group has issued a guideline that outlines the use of 3-D computed tomography (CT)-based radiation therapy planning and volumetric image guidance to more effectively treat pediatric Hodgkin lymphoma and to reduce the radiation dose to normal tissue, thus decreasing the risk of late side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2015 Category: Cancer & Oncology Source Type: news

New Cancer Procedure Eliminates Need For Repeated Radiation Treatments
http://media.boston.cbslocal.com/CBSBOS_0303201517390300000AA.mp4 PEABODY (CBS) – “It was easy. It was simple. It was non-invasive, and I had my life.” Lynn Moriarty of Melrose is talking about her experience with radiation after she was diagnosed with early stage breast cancer last October. Usually a patient has to return every day for three to six weeks, but Lynn had other things she wanted to do. So Lynn’s doctors at Lahey Medical Center Peabody offered her IORT or intraoperative radiation therapy. The patient is brought into the operating room. The surgeon removes the tumor and then a ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 3, 2015 Category: Consumer Health News Authors: deanreddington Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Breast Cancer Dr. Mallika Marshall intraoperative radiation therapy Lahey Medical Center radiation c Source Type: news

Vision RT appoints new sales VP for EMEA, Asia Pacific
Radiation therapy software developer Vision RT has appointed Henrik Andersen (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 3, 2015 Category: Radiology Source Type: news

Computer simulator will improve radiation therapy for cancer patients, experts say
A project to develop a computer simulator of dual foil scattering systems used in radiation therapy is underway. "The user user-friendly interface and real-time nature of the simulator also make it an effective educational tool for gaining a better understanding of the effects that various system parameters have on dose profiles," an author said. "In other words, it will help medical physicists and linear accelerator designers to better understand the physics behind the equipment with which they will be working." (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 3, 2015 Category: Science Source Type: news

Improved survival for patients with brain mets who are 50 and younger and receive SRS alone
(American Society for Radiation Oncology) Cancer patients with limited brain metastases -- one to four tumors -- who are 50 years old and younger should receive stereotactic radiosurgery (SRS) without whole brain radiation therapy, according to a study available online, open-access, and published in the March 15, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 2, 2015 Category: Cancer & Oncology Source Type: news

Varian Medical Systems to Make Radiotherapy Available for More Cancer Patients in Africa
Varian presenting cancer treatment strategy to governments and healthcare leaders at Africa Healthcare Summit in London LONDON, Feb. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (VAR), world leader in radiation therapy, ... Devices, OncologyVarian Medical Systems, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 27, 2015 Category: Pharmaceuticals Source Type: news

Cherenkov Effect Improves Radiation Therapy for Patients with Cancer
Investigators from Dartmouth’s Norris Cotton Cancer Center published new findings about how the complex parts of the blue light known as the Cherenkov Effect can be measured and used in dosimetry to make radiation therapies safer and more effective. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - February 25, 2015 Category: Hospital Management Authors: Geisel Communications Tags: Features News Brian Pogue cancer Norris Cotton Cancer Center radiation therapy research Source Type: news

UCLA study could point toward better decisions for treating men with prostate cancer
UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, the risk to the patient or the patient’s overall prognosis. This finding lays the groundwork for doctors to make more informed decisions about treatment options and provide better information for people with the disease. A team led by Dr. Karim Chamie, an assistant professor of urology at UCLA, analyzed data from 2004 through 2007 for more than 37,000 patients. They found that radiation therapy was the most common treatment for prostate cancer, and that the most s...
Source: UCLA Newsroom: Health Sciences - February 25, 2015 Category: Universities & Medical Training Source Type: news

Cherenkov Effect improves radiation therapy for patients with cancer
(The Geisel School of Medicine at Dartmouth) The characteristic blue glow from a nuclear reactor is present in radiation therapy, too. Investigators from Dartmouth's Norris Cotton Cancer Center published in Physics in Medicine and Biology how the complex parts of the blue light known as the Cherenkov Effect can be measured and used in dosimetry to make therapies safer and more effective. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 25, 2015 Category: Cancer & Oncology Source Type: news

IMV Report Finds New Technology Makes Radiation Therapy More Efficient
New types of radiation therapy technology are making it possible to treat cancer patients more efficiently, requiring fewer trips to treatment facilities, while also spurring interest in capital...(PRWeb February 24, 2015)Read the full story at http://www.prweb.com/releases/2015/02/prweb12531385.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 25, 2015 Category: Pharmaceuticals Source Type: news

IMV: Technology drives radiation therapy market
In addition to enabling more efficient radiation therapy, new technology is (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 24, 2015 Category: Radiology Source Type: news

Radiation Used in Too Many Men With Indolent Prostate CancerRadiation Used in Too Many Men With Indolent Prostate Cancer
American men with low-risk prostate cancer are being overtreated, primarily with radiation therapy, a population-based study has shown. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

The Promise of Combining Radiation Therapy and ImmunotherapyThe Promise of Combining Radiation Therapy and Immunotherapy
Radiation therapy and immunotherapy in partnership may have the capability of delivering a therapeutic effect exceeding the sum of its parts. Future Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2015 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Are Too Many Prostate Cancer Patients Receiving Treatment?
Study also raises concerns about possible overuse of radiation therapy (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 20, 2015 Category: Cancer & Oncology Source Type: news

New study could lead way for better assessment of treatment options for men with prostate cancer
Radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis, researchers have found. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 19, 2015 Category: Science Source Type: news

Are Too Many Prostate Cancer Patients Receiving Treatment?
Study also raises concerns about possible overuse of radiation therapy (Source: WebMD Health)
Source: WebMD Health - February 19, 2015 Category: Consumer Health News Source Type: news

On The Death Of David Carr, And Cancer Survivorship
From an oncologist’s point of view, Carr’s story highlights the need for survivorship care. As his recent autopsy disclosed, he died with an aggressive form of lung cancer and heart disease. Both of these conditions can arise as complications of radiation therapy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 19, 2015 Category: Pharmaceuticals Authors: Elaine Schattner Source Type: news

On The Death Of David Carr, And Cancer Survivorship
From an oncologist?s point of view, Carr?s story highlights the need for survivorship care. As his recent autopsy disclosed, he died with an aggressive form of lung cancer and heart disease. Both of these conditions can arise as complications of radiation therapy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 19, 2015 Category: Pharmaceuticals Authors: Elaine Schattner Source Type: news

Are Too Many Prostate Cancer Patients Receiving Treatment?
Study also raises concerns about possible overuse of radiation therapy Source: HealthDay Related MedlinePlus Pages: Prostate Cancer, Prostate Cancer Screening, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 19, 2015 Category: Consumer Health News Source Type: news

Director's Comments: Use of Short Term Radiation Therapy
Listen to the NLM Director's Comments on Use of Short Term Radiation Therapy. The transcript is also available. Short term radiation treatment (following breast cancer lumpectomies) is increasing for women but most patients receive post-surgical radiation that may be twice as long as necessary, finds a comprehensive study recently published in the Journal of the American Medical Association. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - February 19, 2015 Category: Consumer Health News Source Type: news

Are Too Many Prostate Cancer Patients Receiving Treatment?
Study also raises concerns about possible overuse of radiation therapy (Source: Fertility News - Doctors Lounge)
Source: Fertility News - Doctors Lounge - February 19, 2015 Category: Reproduction Medicine Authors: webmaster at doctorslounge.com Tags: Oncology, Reproductive Medicine, Urology, Geriatrics, News, Source Type: news

Mobius releases software upgrade
Mobius Medical Systems has released an upgrade to its Mobius3D radiation therapy (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 18, 2015 Category: Radiology Source Type: news

54th Annual Particle Therapy Co-Operative Group Conference set for May 18 to May 23 in San Diego
(Scripps Health) International experts in particle beam radiation therapy will gather in San Diego May 18 through May 23 for the 54th annual Particle Therapy Co-Operative Group Conference, hosted by Scripps Proton Therapy Center; University of California, San Diego; and University of Maryland. Attendees will include physicians, researchers, physicists, engineers, nurses, administrators and others. The educational session will be held May 18 to May 20 and the scientific meeting will be May 21 to May 23. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 18, 2015 Category: Global & Universal Source Type: news

54th Annual Particle Therapy Co-Operative Group Conference set for May 18-23 in San Diego
(Scripps Health) International experts in particle beam radiation therapy will gather in San Diego May 18-23 for the 54th annual Particle Therapy Co-Operative Group Conference, hosted by Scripps Proton Therapy Center; University of California, San Diego; and University of Maryland. Attendees will include physicians, researchers, physicists, engineers, nurses, administrators and others. The educational session will be held May 18-20 and the scientific meeting will be May 21-23. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 18, 2015 Category: Cancer & Oncology Source Type: news

'Puzzle': 35% of High-Risk Mastectomy Patients Get No RT'Puzzle': 35% of High-Risk Mastectomy Patients Get No RT
A lot of women with locally advanced breast cancers do not receive the recommended radiation therapy (RT). Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 17, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Too Few Breast Cancer Patients Getting Radiation After Mastectomy
More than a third with 'locally advanced' disease don't get treatment aimed at preventing tumor's return Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Mastectomy, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 17, 2015 Category: Consumer Health News Source Type: news

ViewRay registers for $69m IPO
ViewRay registers for an initial public offering worth up to $69 million for its MRIdian cancer detection and radiation treatment device. ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously." ViewRay Inc.News Well, Imaging, Initial Public Offering (IPO), Radiosurgery, Wall Street Beatread more (Source: Mass Device)
Source: Mass Device - February 16, 2015 Category: Medical Equipment Authors: Brad Perriello Source Type: news

Immune begins Phase I trial of G100 to treat metastatic sarcoma
Immune Design, a US-based clinical-stage immunotherapy firm, has initiated an investigator-sponsored Phase I clinical trial of its investigational immuno-oncology agent, G100, in combination with radiation therapy in patients with metastatic sarcoma. (Source: Drug Development Technology)
Source: Drug Development Technology - February 12, 2015 Category: Pharmaceuticals Source Type: news

Where Do Patients with Cancer in Iowa Receive Radiation Therapy?
Describes the concerns affecting access to cancer treatment in rural and urban areas in Iowa. (Source: Rural publications via the Rural Assistance Center)
Source: Rural publications via the Rural Assistance Center - February 11, 2015 Category: Rural Health Source Type: news

UTSW receives key NCI funding to plan first U.S. Center for Heavy Ion Radiation Therapy Research
The National Cancer Institute (NCI) of the National Institutes of Health awarded UT Southwestern a $1 million planning grant to establish the country’s first National Center for Heavy Ion Radiation Therapy. (Source: UT Southwestern Medical Center News)
Source: UT Southwestern Medical Center News - February 10, 2015 Category: Hospital Management Source Type: news

Many mastectomy patients with locally advanced breast cancer do not get postop radiation
(American College of Surgeons) Breast cancer patients who undergo a mastectomy should receive subsequent radiation treatment if their cancer has spread to four or more nearby lymph nodes, however, according to a new study, only 65 percent of these women are getting the recommended postmastectomy radiation therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 9, 2015 Category: Global & Universal Source Type: news